chr1-1013997-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005101.4(ISG15):c.17C>T(p.Thr6Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000319 in 1,599,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T6K) has been classified as Uncertain significance.
Frequency
Consequence
NM_005101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ISG15 | NM_005101.4 | c.17C>T | p.Thr6Met | missense_variant | 2/2 | ENST00000649529.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ISG15 | ENST00000649529.1 | c.17C>T | p.Thr6Met | missense_variant | 2/2 | NM_005101.4 | P1 | ||
ISG15 | ENST00000624652.1 | c.-8C>T | 5_prime_UTR_variant | 3/3 | 3 | ||||
ISG15 | ENST00000624697.4 | c.-8C>T | 5_prime_UTR_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152240Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000106 AC: 26AN: 245710Hom.: 0 AF XY: 0.0000677 AC XY: 9AN XY: 132938
GnomAD4 exome AF: 0.0000304 AC: 44AN: 1446852Hom.: 0 Cov.: 31 AF XY: 0.0000279 AC XY: 20AN XY: 716818
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152358Hom.: 0 Cov.: 35 AF XY: 0.0000268 AC XY: 2AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The c.17C>T (p.T6M) alteration is located in exon 2 (coding exon 2) of the ISG15 gene. This alteration results from a C to T substitution at nucleotide position 17, causing the threonine (T) at amino acid position 6 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 02, 2022 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 6 of the ISG15 protein (p.Thr6Met). This variant is present in population databases (rs199853706, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with ISG15-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at